[pending] EPTIFIBATIDE (EPTIFIBATIDE)
Pending LLM rewrite. Source: FDA_DRUG D-0343-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.
The recalled product
- Product
- EPTIFIBATIDE (EPTIFIBATIDE)
- Brand
- EPTIFIBATIDE
- Manufacturer
- Slate Run Pharmaceuticals
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry
UPCs (2)
- 0370436027804
- 0370436163809
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · EPTIFIBATIDE
- ModerateDrug Recall: Eptifibatide Injection Due to Failed Degradation Specifications
FDA (Drugs) · 2024-06-26
Same category
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22